Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Prospective identification of tumorigenic breast cancer cells
2003 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma.
1990
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Untangling the ErbB signalling network
2001 Standout
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.
1997
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.
1996
Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer
2016
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
2012
The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review
1995
Amplification of fgfr4 gene in human breast and gynecological cancers
1993
Targeted Therapy in Breast Cancer
2004
Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas.
1995
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 Standout
Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry for the Evaluation of HER-2/neu in Breast Cancer
1999
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers
2008
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
2002 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Estrogen Receptors and Distinct Patterns of Breast Cancer Relapse
2003
Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials
2001
The Cellular Basis of Tumor Progression
1997
Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease
2010
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Mammaglobin Gene Expression: A Superior Marker of Breast Cancer Cells in Peripheral Blood in Comparison to Epidermal-Growth-Factor Receptor and Cytokeratin-19
2000
Contribution of platelets to tumour metastasis
2011 Standout
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Benefits and risks of menopausal estrogen and/or progestin hormone use
1988
Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy
1994
Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy
1995
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
REVIEW: Detection of circulating breast cancer cells by reverse transcriptase polymerase chain reaction (RT-PCR)
2000
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
2001 Standout
DETECTION OF DISSEMINATED TUMOR CELLS IN PERIPHERAL BLOOD
2005
Naturally occurring B-cell responses to breast cancer
2003
HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.
1992
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
The prognostic value of p53 and c-erb b-2 immunostaining is overrated for patients with lymph node negative breast carcinoma
2000
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
EGF–ERBB signalling: towards the systems level
2006 Standout
Significance, detection and markers of disseminated breast cancer cells
2006
Circulating tumour cells in breast cancer
2004
Detection of estrogen receptor in bone marrow from patients with metastatic breast cancer.
1987
Trastuzumab‐associated cardiotoxicity
2002
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
2001 Standout
VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors
2011
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Natural selection in neoplastic progression of Barrett's esophagus
2005
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Calcium-binding protein S100A4 in health and disease
1998
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation
2011
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Protein tyrosine kinases and cancer
1997
Clonal evolution in cancer
2012 StandoutNature
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Cancer as an evolutionary and ecological process
2006 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast Cancer
2005
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Breast cancer metastasis: markers and models
2005 Standout
Sequence and structure-based prediction of eukaryotic protein phosphorylation sites
1999 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
In situ cytokine production by breast cancer tumor-infiltrating lymphocytes
1996
Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research
2011
Heterogeneity in Breast Cancer and the Problem of Relevance of Findings
1999
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.
1992
Clinical Usefulness of Estrogen Receptor Immunocytochemistry in Human Breast Cancer
1992
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
2002 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Western diet and Western diseases: Some hormonal and biochemical mechanisms and associations
1990
Mechanisms of Estrogen Action
2001 Standout
Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance
2002
2000 Update of Recommendations for the Use of Tumor Markers in Breast and Colorectal Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*
2001
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
Role of HER2 gene overexpression in breast carcinoma
2000
Estrogen and Coronary Heart Disease in Women
1991 Standout
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
COAGULATION DISORDERS IN CANCER
1996
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
2007 Standout
Epithelial-mesenchymal transition and its implications for fibrosis
2003 Standout
Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor.
1991
Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility
1994
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood
2001
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
2001
Works of W.D. George being referenced
The long term prognostic significance of c-erbB-2 in primary breast cancer
1991
Altered lymphocyte populations in tumour invaded nodes of breast cancer patients
1993
Flow cytometric analysis of tumour infiltrating lymphocyte activation and tumour cell MHC Class I and II expression in breast cancer patients
1992
Characterization of Extensive Genetic Alterations in Ductal Carcinoma In Situ by Fluorescence In Situ Hybridization and Molecular Analysis
1995
Aneuploid subpopulations in tumour-invaded lymph nodes from breast cancer patients
1992
Putative markers for the detection of breast carcinoma cells in blood
1998
Experimental colorectal cancer: The relationship of diet and faecal bile acid concentration to tumour induction
1986
Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer
1990
Surgical reasearch society. Pre-operative determination of oestrogen receptor status in breast cancer by immunocytochemical staining of fine needle aspirates
1985
In Vivo Measurements of Fibrin Formation and Fibrinolysis in Operable Breast Cancer
1989
Tumour bed positivity predicts outcome after breast-conserving surgery
1997
The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast
1991
Comparison of breast cancer mortality rates with those of ovarian and colorectal carcinoma
2007
Warfarin inhibition of metastasis: The role of anticoagulation
1987
Evaluation of luteal-phase salivary progesterone levels in women with benign breast disease or primary breast cancer
1985